Summary

This volume's central thesis is that telomerase activity, while essential for cellular immortality and organismal longevity, plays a dual role in cancer development. It directly enables tumor cells to bypass senescence and achieve replicative immortality, a critical step in tumorigenesis. However, the book also explores how telomerase's presence is not universally required for all cancers and can be influenced by telomere maintenance mechanisms like the alternative lengthening of telomeres (ALT).

The work details the molecular mechanisms of telomere replication and the function of telomerase as a reverse transcriptase. It highlights the therapeutic potential of targeting telomerase to inhibit cancer cell proliferation, while also acknowledging the challenges and complexities inherent in developing such treatments due to its normal physiological roles. The reader gains a nuanced understanding of telomere biology and its intricate link to cancer progression and potential therapeutic strategies.

Full text isn't indexed yet — this overview draws on general knowledge of the book and its metadata, and chat works the same way.

Key concepts

Telomerase — A reverse transcriptase enzyme that adds repetitive DNA sequences to the ends of eukaryotic chromosomes (telomeres).
Telomeres — Protective caps at the ends of chromosomes that shorten with each cell division.
Replicative immortality — The ability of a cell to divide indefinitely without undergoing senescence.
Senescence — A state of irreversible cell cycle arrest.
Alternative Lengthening of Telomeres (ALT) — A telomere maintenance mechanism that does not involve telomerase, often found in cancers lacking telomerase activity.